MTOR and hyperthyroidism: Zhang et al. demonstrated that rapamycin, a mTOR inhibitor, ameliorated orbitopathy and hyperthyroidism by decreasing CD4+ CTLs’ accumulation and suppressing their inflammatory in GO mice.